I discuss issues pertaining to the practice of neuropathology -- including nervous system tumors, neuroanatomy, neurodegenerative disease, muscle and nerve disorders, ophthalmologic pathology, neuro trivia, neuropathology gossip, job listings and anything else that might be of interest to a blue-collar neuropathologist.
Friday, November 28, 2008
Even Cowdry himself wasn't so sure of the significance of the Cowdry B inclusion
Monday, November 24, 2008
Best Post of August '08: Loss of von Economo neurons may be associated with frontotemporal dementia
With that update, I now present my "Best of the Month" post for August '08:
On Wednesday [Aug 6 '08], I wrote about the fact that the brains of gorillas weigh only about 40% as much as human brains. There is, however, one way in which our brains are similar to simians: the presence of the von Economo neuron (VEN).
Constantin von Economo demonstrated in the 1920’s that these neurons are present only in the anterior cingulate and insular cortices (layer Vb). It was later determined that VENs are only present in hominids (humans and great apes), and that they are more numerous on the right side of the brain. Also referred to as spindle neurons because of their spindle-shaped cell bodies, VENs are larger than pyramidal neurons and tend to cluster parallel to small arterioles (pictured on right as compared to pyramidal neuron). More recently, it was found that VENs are also present in various species of whales and in elephants. The common theme here is that VENs are present in social animals with large brains. Since the VEN-populated areas of the brain are preferentially affected in frontotemporal dementia (FTD), it is thought that perhaps loss of these neurons may be related to the aberrant social functioning seen in FTD patients.
Thursday, November 20, 2008
Senator Ted Kennedy's malignant brain tumor not keeping him from work on The Hill
It remarkable that Kennedy hasn't simply retired, given his grave diagnosis. His example is truly a profile in courage.
The VOA report goes on to say that "the Massachusetts senator, who was first elected in 1962, underwent surgery in June for a malignant brain tumor. He made a brief appearance in the Senate in July, and delivered a speech supporting Mr. Obama at the Democratic National Convention in August."
Monday, November 17, 2008
Neuropathology Blog featured on CAP Transformation Campaign Website
Thursday, November 13, 2008
Whither the Illusory Cowdry B Inclusion of Polio?
-->
-->
Saturday, November 8, 2008
Surgical Science Museum in Chicago Features Surgicogenomics Exhibit
Friday, November 7, 2008
nNOS: The Canary in the Mine
Campbell and colleagues address the phenomenon of exaggerated muscle fatigue after exercise, a finding present in many neuromuscular disorders. Using mouse models, the Campbell lab showed that sarcolemma-localized signalling by nNOS in skeletal muscle is required to maintain activity after mild exercise. To quote the abstract: "We show that nNOS-null mice do not have muscle pathology and have no loss of muscle-specific force after exercise but do display this exaggerated fatigue response to mild exercise.... Our findings suggest that the mechanism underlying the exaggerated fatigue response to mild exercise is a lack of contraction-induced signalling from sarcolemma-localized nNOS, which decreases cGMP-mediated vasomodulation in the vessels that supply active muscle after mild exercise. Sarcolemmal nNOS staining was decreased in patient biopsies from a large number of distinct myopathies, suggesting a common mechanism of fatigue. Our results suggest that patients with an exaggerated fatigue response to mild exercise would show clinical improvement in response to treatment strategies aimed at improving exercise-induced signalling." It is interesting that there was no histomorphological pathology in the nNOS-null mice, suggesting that nNOS histochemical staining of patient biopsies might reveal an underlying disease process in otherwise non-specific biopsy findings. Or, as Steve Moore put it, nNOS can function as the "canary in the mine" for detecting myopathies.
Wednesday, November 5, 2008
Best Post of July, 2008: "What is nNOS? And why is nNOS histochemistry useful in muscle biopsies?"
From time to time, I feature an installment of my “Best Post Of The Month” series. The next month up for review is July '08, and I feel that this was the best item posted that month:
WHAT IS nNOS? AND WHY IS nNOS HISTOCHEMISTRY USEFUL IN MUSCLE BIOPSIES?
I recently sent a specimen out for histochemistry to see if the muscle had diminished dystrophin and/or dystrophin-associated proteins. One of the histochemical stains in the panel was neuronal nitric oxide synthase (nNOS). I honestly didn’t know what the deal was with that particular protein, so I thought I’d share with you what I found out.
In normal muscle, histochemistry for nNOS shows uniform sarcolemmal labeling. Internal sarcoplasmal labeling can also be present. Blood vessel walls are also positive. In Duchenne or Becker muscular dystrophy, nNOS is absent or reduced in the sarcolemma. Immature fibers will also lack nNOS histochemical staining.
An article by Ehmsen et al in the Journal of Cell Science states the following: “The production of nitric oxide (NO) by nNOS is important for increasing local blood flow to match the increased metabolic load of contracting muscles, such as during exercise… [P]atients with DMD [Duchenne muscular dystrophy] show abnormal blood vessel constriction presumably due to lack of nNOS at the sarcolemma… However, abolishing nNOS expression alone in mice does not cause overt dystrophy.”
So if it doesn’t cause overt dystrophy, what’s the point of doing this particular histochemical stain?
Dr. Steve Moore (pictured), muscle pathology guru at the University of Iowa, emailed me the following response when I queried him on the subject: “[nNOS] is quite sensitive to dystrophin mutations, meaning that it is virtually always absent in DMD and reduced to absent in BMD. In milder cases of BMD, nNOS sometimes can be the "canary in the mine" for detecting a dystrophinopathy. In the setting of a possible dystrophin mutation carrier, it provides one more marker for the muscle cells expressing either normal or mutant dystrophin. Dystrophin-negative fibers are also nNOS negative. This contrasts with the dystrophin-negative fibers being utrophin positive (utrophin is frequently expressed at the sarcolemma when dystrophin is missing or abnormal). Bottom line - using nNOS increases my confidence in the interpretation of the other immunostains in selected cases.”
References:
Dubowitz V and Sewry CA. Muscle Biopsy: A Practical Approach, 3rd edition (2007) p 261 and 279.
Ehmsen J et al., The dystrophin-associated protein complex. Journal of Cell Science 115 (14) p. 2801-3.
Sunday, November 2, 2008
The Mutter Museum in Philadelphia Provides a Unique Perspective on Neuroanatomy
Karen Everingham -- formerly of the Illinois Association of Museums and now of the Historic Sites Division of the Illinois Historic Preservation Agency -- told me about an unusual medical museum sponsored by the College of Physicians of Philadelphia called the Mutter Museum. Among the medical curios and artifacts housed at the Mutter is a unique set of sliced sections of the human head prepared for the museum in 1910. What's special about this series of sections is that it demonstrates the human brain in situ within the context of the entire head. The first section in the series (pictured) shows the face of the subject sectioned. The next time I'm in Philadephia, I will surely visit the Mutter. Thanks, Karen!
Neuropathology Blog is Signing Off
Neuropathology Blog has run its course. It's been a fantastic experience authoring this blog over many years. The blog has been a source...
-
Shannon Curran, MS with her dissection Shannon Curran, a graduate student in the Modern Human Anatomy Program at the University of Co...
-
Neuropathology Blog has run its course. It's been a fantastic experience authoring this blog over many years. The blog has been a source...